FDA clears Dexcom’s Stelo as first OTC Continuous Glucose Monitor for kids
Expanded indication makes Stelo the first FDA-cleared OTC CGM for children aged two years and older with diabetes or prediabetes
Expanded indication makes Stelo the first FDA-cleared OTC CGM for children aged two years and older with diabetes or prediabetes
The study enrolled 639 patients, nearly 80% of whom had previously received a covalent BTK inhibitor
The FDA nod marks a step forward in precision oncology, linking molecular diagnostics more tightly to therapy selection for advanced prostate cancer
Production at Vadodara facility strengthens Make in India initiative, enhances access to diagnostic testing, and supports preventive healthcare across the country
Collaboration to deploy Philips’ IntelliBridge Enterprise platform across Bajaj Integrated Health System network, enabling seamless patient data flow and integrated care delivery.
Discussions focus on integrating ECG diagnostics into AI-enabled E-ICU Command Centre and expanding technology-driven healthcare access across underserved regions
MabionCD20 is a monoclonal antibody originally developed by Mabion as a biosimilar candidate to MabThera and Rituxan therapies
Exclusive partnership introduces globally benchmarked stem cell processing platform aimed at improving stem cell recovery, quality, and long-term therapeutic potential
Veteran quality professional with over 20 years of industry experience to lead quality operations at Unit-4 API manufacturing facility
Subscribe To Our Newsletter & Stay Updated